Azitra, Inc. AZTR
Set alert
At close · Oct 30
After hours · Oct 30, 7:57 PM ET
- YTD
- -70.97%
- 1 year
- -86.96%
- Open
- 0.712
- Prev close
- 0.7571
- Mkt cap
- 4.66M
- Vol
- 787.87K
- Avg vol
- 2.64M
- EPS
- -2.80
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.6511
- High
- 0.7899
- Forward P/E
- -0.78
- Beta
- 0.00
- Short ratio
- 1.34
- Inst. own
- 1.82%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.49486
- 200-d avg
- 2.79
- 1y target
- 3.50
5D chart
Events in this range
- Oct 26, 2026Split: 1 for 10
Signals (88)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 3:40 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:35 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:10 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:30 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 1:10 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 11:35 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:30 AM | 2 days ago |
| RSI: Oversold | Oct 30, 10:50 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:45 AM | 2 days ago |
| RSI: Oversold | Oct 30, 10:30 AM | 2 days ago |
| RSI: Oversold | Oct 30, 10:05 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 3:45 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:40 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 2:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:50 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:05 PM | 3 days ago |
| SMA: Bullish | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:45 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:10 AM | 3 days ago |
| RSI: Oversold | Oct 29, 9:45 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 9:30 AM | 3 days ago |
| RSI: Oversold | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:00 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:35 AM | 4 days ago |
| RSI: Oversold | Oct 28, 11:25 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 11:15 AM | 4 days ago |
| RSI: Oversold | Oct 28, 11:05 AM | 4 days ago |
| RSI: Oversold | Oct 28, 9:55 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 5 days ago |
| RSI: Oversold | Oct 27, 12:50 PM | 5 days ago |
| RSI: Oversold | Oct 27, 12:40 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:30 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:50 AM | 5 days ago |
| RSI: Oversold | Oct 27, 11:50 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:25 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:30 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:15 AM | 5 days ago |
| RSI: Oversold | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 26, 2:40 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:40 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:40 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:15 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:10 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:10 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:45 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:25 PM | 6 days ago |
| RSI: Overbought | Oct 26, 12:50 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 12:40 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:20 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:55 AM | 6 days ago |
| SMA: Bullish | Oct 26, 11:50 AM | 6 days ago |
| SMA: Bearish | Oct 26, 11:45 AM | 6 days ago |
| SMA: Bullish | Oct 26, 10:45 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:30 AM | 6 days ago |
News
-
3 days ago benzinga.com
Azitra Expands Eligibility For Ongoing Phase 1/2 Clinical Trial Of ATR04-484 To Include Individuals With Rash Associated With KRAS And MEK Inhibitors
Expanded eligibility significantly broadens potential treatment opportunities for ATR-04 beyond EGFR inhibitor-associated skin rashAdditional protocol modifications expected to facilitate patient…
3 days ago prnewswire.com
Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes due to KRAS and MEK Inhibitors
Expanded eligibility significantly broadens potential treatment opportunities for ATR-04 beyond EGFR inhibitor-associated skin rash Additional protocol modifications expected to facilitate patient…
5 days ago benzinga.com
Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Celestica jumps 16.4% after beating Q3 FY26 estimates and raising guidance; 22nd Century leads premarket gainers at 69.8%.
-
6 days ago benzinga.com
Azitra Suspends ATM Offering Program For The Foreseeable Future; From September 28, 2026 - October 26, 2026, The Company Sold An Aggregate Of 1,000 Shares Of Common Stock Under The ATM Program For Aggregate Gross Proceeds Of ~$126
ATM Program Effective October 26, 2026, the Company has decided not to utilize its at-the-market offering program (the "ATM Program") under the sales agreement, dated September 28, 2026, between the…
-
6 days ago benzinga.com
Azitra To Present Progress For Its Cosmetic ATR-COSF Program Targeting Fine Lines And Wrinkles At Bio-europe, November 10; First-In-Human Study With ATR-COSF Initial Results Anticipated By End Of 2026
ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the protein, filaggrin.Ex vivo data in two models of recent cosmetic surgery explants showed visible…
6 days ago prnewswire.com
Azitra, Inc. Announces Revitalizing Results from Ex Vivo Study of ATR-COSF Demonstrating Ability to Reduce Fine Lines and Improve Elasticity in Human Skin
ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the protein, filaggrin. Ex vivo data in two models of recent cosmetic surgery explants showed visible…
2 weeks ago prnewswire.com
Azitra, Inc. Announces Reverse Stock Split
Common Stock Will Begin Trading on a Split-Adjusted Basis on October 26, 2026 BRANFORD, Conn., Oct. 16, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical…
2 weeks ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Alaunos Therapeutics (NASDAQ:TCRT) stock moved upwards by 203.8% to $3.19 during Tuesday's regular session. The company's market cap stands at $2.6 million. Picard Medical (AMEX:PMI) stock…
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 64.0% to $2.05 during Tuesday's after-market session. The market value of their outstanding shares is at $1.1 million. Neogen…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-market session. The market value of their outstanding shares is at $34.9 million. Intelligent Bio Solutions…
1 month ago prnewswire.com
Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance
BRANFORD, Conn., Oct. 1, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for…
1 month ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Evogene (NASDAQ:EVGN) shares increased by 75.0% to $0.72 during Tuesday's after-market session. The company's market cap stands at $4.5 million. AIxCrypto Hldgs (NASDAQ:AIXC) stock moved…
1 month ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Stablecoin Development (AMEX:SDEV) stock increased by 121.6% to $3.48 during Tuesday's regular session. The market value of their outstanding shares is at $42.5 million. Iovance…
1 month ago defenseworld.net
Azitra, Inc. (NYSEAMERICAN:AZTR) Sees Significant Drop in Short Interest
Azitra, Inc. (NYSEAMERICAN:AZTR - Get Free Report) was the recipient of a large drop in short interest in September. As of September 15th, there was short interest totaling 701,345 shares, a drop of…
1 month ago prnewswire.com
Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
BRANFORD, Conn., Sept. 8, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies…
-
2 months ago benzinga.com
Azitra Regains NYSE American Compliance
Azitra, Inc. ("Azitra" or the "Company") (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology and high value cosmetic proteins…
2 months ago prnewswire.com
Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards
BRANFORD, Conn., Aug. 21, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies…
-
2 months ago benzinga.com
Anitra Q2 EPS $(0.17) Misses $(0.12) Estimate
Anitra (AMEX:AZTR) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.12) by 54.55 percent. This is a 85.95 percent increase over losses of $(1.21) per…
2 months ago prnewswire.com
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates
BRANFORD, Conn., Aug. 12, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies…
-
3 months ago benzinga.com
Azitra Reports Results From Two Ex Vivo Human Skin Tissue Studies Evaluating Distribution And Anti-Wrinkle Activity Of Filaggrin Domain Supernatant
ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the protein, filaggrin ("rHDfilaggrin"). This S. epidermis derived supernatant is in development as a…
-
3 months ago benzinga.com
Azitra Announce Ex Vivo Results From Two Human Skin Tissue Studies Evaluating Anti-Wrinkle Activity In Filaggrin Domain Containing Supernatant
ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the protein, filaggrin ("rHDfilaggrin"). This S. epidermis derived supernatant is in development as a…
3 months ago prnewswire.com
Azitra, Inc. Announces Breakthough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity
ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the protein, filaggrin ("rHDfilaggrin"). This S. epidermis derived supernatant is in development as a…
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-market session. The market value of their outstanding shares is at $77.1 million. Bio-Techne…
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market session. The company's market cap stands at $5.6 million. Boundless Bio (NASDAQ:BOLD) shares rose 62.85% to…
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-market session. The company's market cap stands at $4.0 million. Aditxt (NASDAQ:ADTX) shares rose 84.99% to…
4 months ago benzinga.com
Why Sagtec Global Shares Are Trading Higher By Around 76%; Here Are 20 Stocks Moving Premarket
SAGTEC GLOBAL (NASDAQ: SAGT) gained 75.6% in pre-market trading after projecting 35% revenue growth in 2026. Other gainers include EHGO, GETY, TNON, AZTR, CDT, APGE, ADTX, MLTX, and SYRE. Losers…
4 months ago benzinga.com
Why Did Azitra (AZTR) Stock Jump Over 25% After Hours?
Azitra shares jumped 25.45% after-hours following volatile trading session, financing updates and upcoming biotech presentation plans.
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
4 months ago benzinga.com
Azitra To Pause Further Enrollment In ATR-12 Trial To Redirect Funds To ATR-COSF
New Initiatives:ATR-COSF: Expansion into Cosmetic IngredientsOne of the most exciting initiatives enabled by the March financing is ATR-COSF, a recombinant filaggrin protein program designed for the…
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
4 months ago prnewswire.com
Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond
BRANFORD, Conn., June 17, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies…
4 months ago prnewswire.com
Azitra, Inc. to Present at 2026 BIO International Convention
/PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
5 months ago prnewswire.com
Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting
BRANFORD, Conn., June 4, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology,…
5 months ago prnewswire.com
Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting
BRANFORD, Conn., May 27, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology,…
5 months ago prnewswire.com
Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates
BRANFORD, Conn., May 13, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for…
5 months ago prnewswire.com
Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program
Patent offers broad protections for ATR-12, an engineered strain of S. epidermidis that expresses a fragment of human LEKTI protein ATR-12 is currently the subject of a Phase 1b trial for the…
6 months ago prnewswire.com
Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris
Preclinical data demonstrate ATR-01 delivers functional filaggrin, restoring skin barrier integrity and supporting advancement toward first-in-human studies BRANFORD, Conn., April 28, 2026…
7 months ago benzinga.com
Why Are Shares Of Azitra Rising?
Azitra's spike is being fueled by a securities purchase agreement with healthcare-focused institutional investors for gross proceeds of up to $31.4 million, with Series B and C warrants exercisable…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
7 months ago benzinga.com
Dow Falls Over 100 Points; FedEx Posts Upbeat Earnings
Dow falls 100+ points, S&P 500 and NASDAQ also down. Energy sector sees gains, consumer discretionary falls. FedEx beats expectations, raises guidance. Azitra and Co-Diagnostics soar, Super Micro…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
7 months ago benzinga.com
Why Planet Labs Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Planet Labs (PL) stock rose in pre-market trading after better-than-expected Q4 sales and strong FY27 guidance. Top gainers include JDZG, AZTR, YYGH, DRMA, WNW, RPGL, JEM, FDX, and FLY. Top losers…
7 months ago feeds.benzinga.com
Azitra Inc. (AZTR) Surges Over 44% After Hours— Here's Why It's Trending
Azitra shares jumped over 44% in after-hours trading following a $31.4 million financing deal to advance its filaggrin protein and peptide platform.
7 months ago prnewswire.com
Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million
Initial funding of approximately $10.5MM in convertible preferred stock and up to an additional $20.9MM upon cash exercise of warrants Financing marks launch of Azitra new innovative protein and…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
7 months ago prnewswire.com
Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement
BRANFORD, Conn., March 13, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology,…
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session